Dr. Gary Steinberg on New AUA Guidelines for Bladder Cancer

Gary D. Steinberg, MD
Published: Monday, Jun 27, 2016



Gary D. Steinberg, MD, Bruce and Beth White family professor, professor of surgery, director, urologic oncology, University of Chicago Medicine, discusses new guidelines for for the management of non-muscle invasive bladder cancer (NMIBC) from the American Urological Association (AUA) and the Society of Urological Oncology (SUO).
 
The new guidelines were created from a compilation of all of the latest literature and the input of many experts in the field, says Steinberg. The guidelines include information concerning diagnosis, risk stratification, variant histologies, urine markers after diagnosis, intravesical therapy, BCG relapse and salvage regimens, TURBT/repeat resection, role of cystectomy, and risk adjusted surveillance and follow-up strategies.
 
The guidelines are succinct and straight-forward providing oncologists with a much better understanding as to how patients should  be managed and treated.
 
SELECTED
LANGUAGE


Gary D. Steinberg, MD, Bruce and Beth White family professor, professor of surgery, director, urologic oncology, University of Chicago Medicine, discusses new guidelines for for the management of non-muscle invasive bladder cancer (NMIBC) from the American Urological Association (AUA) and the Society of Urological Oncology (SUO).
 
The new guidelines were created from a compilation of all of the latest literature and the input of many experts in the field, says Steinberg. The guidelines include information concerning diagnosis, risk stratification, variant histologies, urine markers after diagnosis, intravesical therapy, BCG relapse and salvage regimens, TURBT/repeat resection, role of cystectomy, and risk adjusted surveillance and follow-up strategies.
 
The guidelines are succinct and straight-forward providing oncologists with a much better understanding as to how patients should  be managed and treated.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Publication Bottom Border
Border Publication
x